Showing 1 - 10 of 1,849
This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …
Persistent link: https://www.econbiz.de/10005699276
In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising …
Persistent link: https://www.econbiz.de/10010670125
that may profitably be considered by India today. The Indian patent system emphasizes the patentability requirement in … contrast to the Japanese patent policy which relied on narrow patents and extensive licensing. R&D by local firms and the …
Persistent link: https://www.econbiz.de/10005744786
pharmaceuticals have an important impact on public health, government actions are necessarily involved, which have a major effect on …
Persistent link: https://www.econbiz.de/10010764264
This paper introduces a novel method for examining the effects of vertical integration. The basic idea is to estimate the parameters of a vertical entry game. By carefully specifying firms' payoff equations and constructing appropriate tests, it is possible to use estimates on rival profit...
Persistent link: https://www.econbiz.de/10008615350
Vor dem Hintergrund der weiter wachsenden Bedeutung der Volksrepublik China in der Weltwirtschaft beschäftigt sich die Arbeit mit dem dortigen Schutz von Patenten. Das chinesische Patentsystem entspricht dem internationalen Standard des TRIPS-Übereinkommens. Die Analyse von Patentanmeldungen...
Persistent link: https://www.econbiz.de/10008784575
Статья посвящена анализу фармацевтических рынков стран ЕС и СНГ, их проблемам и перспективам развития. Исследована динамика развития европейского...
Persistent link: https://www.econbiz.de/10011271214
With the expiry of the Pharmaceutical Industry Investment Program (PIIP) in 2004, the Commission was asked to conduct an evaluation of the program’s rationale, effectiveness and efficiency. The study commenced in August 2002. The Commission found that this assistance scheme had significant...
Persistent link: https://www.econbiz.de/10005077086
price of brand name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper …, the introduction of the substitution reform in the Swedish pharmaceuticals market in October 2002 is used as a natural … reform has lowered the price of both brand name- and generic pharmaceuticals. …
Persistent link: https://www.econbiz.de/10005652004
long run benefits from fostering generic entry and post-patent competition into the markets. …
Persistent link: https://www.econbiz.de/10005771939